Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Cyclacel Pharmaceuticals, Inc. | c14674e10vk.htm |
| EX-21 - EXHIBIT 21 - Cyclacel Pharmaceuticals, Inc. | c14674exv21.htm |
| EX-3.2 - EXHIBIT 3.2 - Cyclacel Pharmaceuticals, Inc. | c14674exv3w2.htm |
| EX-32.2 - EXHIBIT 32.2 - Cyclacel Pharmaceuticals, Inc. | c14674exv32w2.htm |
| EX-31.1 - EXHIBIT 31.1 - Cyclacel Pharmaceuticals, Inc. | c14674exv31w1.htm |
| EX-31.2 - EXHIBIT 31.2 - Cyclacel Pharmaceuticals, Inc. | c14674exv31w2.htm |
| EX-32.1 - EXHIBIT 32.1 - Cyclacel Pharmaceuticals, Inc. | c14674exv32w1.htm |
| EX-10.14 - EXHIBIT 10.14 - Cyclacel Pharmaceuticals, Inc. | c14674exv10w14.htm |
| EX-10.13 - EXHIBIT 10.13 - Cyclacel Pharmaceuticals, Inc. | c14674exv10w13.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No.
333-143786) pertaining to the 2006 Equity Incentive Plan of Cyclacel Pharmaceuticals, Inc. of our
report dated March 31, 2011, with respect to the consolidated financial statements of Cyclacel
Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31,
2010.
| /s/ Ernst & Young LLP |
London, England
March 31, 2011
March 31, 2011